154 related articles for article (PubMed ID: 35278407)
1. Urinary mi-106a for the diagnosis of IgA nephropathy: Liquid biopsy for kidney disease.
Szeto CC; Ng JK; Fung WW; Chan GC; Luk CC; Lai KB; Wang G; Chow KM; Mac-Moune Lai F
Clin Chim Acta; 2022 May; 530():81-86. PubMed ID: 35278407
[TBL] [Abstract][Full Text] [Related]
2. Urinary miRNA profile for the diagnosis of IgA nephropathy.
Szeto CC; Wang G; Ng JK; Kwan BC; Mac-Moune Lai F; Chow KM; Luk CC; Lai KB; Li PK
BMC Nephrol; 2019 Mar; 20(1):77. PubMed ID: 30832601
[TBL] [Abstract][Full Text] [Related]
3. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
Liang S; Cai GY; Duan ZY; Liu SW; Wu J; Lv Y; Hou K; Li ZX; Zhang XG; Chen XM
BMC Nephrol; 2017 Feb; 18(1):63. PubMed ID: 28201996
[TBL] [Abstract][Full Text] [Related]
4. Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy.
Zhang Q; Zhao Y; Luo Y; Guo S; Hou H; Han X; Zhou Y
Ren Fail; 2024 Dec; 46(1):2319326. PubMed ID: 38379319
[TBL] [Abstract][Full Text] [Related]
5. Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy.
Zhang M; Duan ZY; Zhang QY; Xu XG; Zhang Y; Wang P; Duan SW; Wu J; Chen XM; Cai GY
Sci Rep; 2023 Apr; 13(1):6048. PubMed ID: 37055445
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of urinary exosomal microRNAs in IgA nephropathy.
Min QH; Chen XM; Zou YQ; Zhang J; Li J; Wang Y; Li SQ; Gao QF; Sun F; Liu J; Xu YM; Lin J; Huang LF; Huang B; Wang XZ
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28383146
[TBL] [Abstract][Full Text] [Related]
7. Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy.
Duan ZY; Cai GY; Bu R; Lu Y; Hou K; Chen XM
Sci Rep; 2016 Mar; 6():23498. PubMed ID: 27000966
[TBL] [Abstract][Full Text] [Related]
8. Expression of microRNAs in the urinary sediment of patients with IgA nephropathy.
Wang G; Kwan BC; Lai FM; Chow KM; Kam-Tao Li P; Szeto CC
Dis Markers; 2010; 28(2):79-86. PubMed ID: 20364043
[TBL] [Abstract][Full Text] [Related]
9. In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy.
Serino G; Pesce F; Sallustio F; De Palma G; Cox SN; Curci C; Zaza G; Lai KN; Leung JC; Tang SC; Papagianni A; Stangou M; Goumenos D; Gerolymos M; Takahashi K; Yuzawa Y; Maruyama S; Imai E; Schena FP
Kidney Int; 2016 Mar; 89(3):683-92. PubMed ID: 26581012
[TBL] [Abstract][Full Text] [Related]
10. Urinary Exosomal MicroRNAs as New Noninvasive Biomarkers of IgA Nephropathy.
Li S; Hao H; Li R; Guo S
Tohoku J Exp Med; 2022 Mar; 256(3):215-223. PubMed ID: 35314529
[TBL] [Abstract][Full Text] [Related]
11. U6 can be used as a housekeeping gene for urinary sediment miRNA studies of IgA nephropathy.
Duan ZY; Cai GY; Li JJ; Bu R; Wang N; Yin P; Chen XM
Sci Rep; 2018 Jul; 8(1):10875. PubMed ID: 30022109
[TBL] [Abstract][Full Text] [Related]
12. A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity.
Han QX; Wang Y; Zhu HY; Zhang D; Gao J; Liu ZS; Cai GY; Chen XM
Chin Med J (Engl); 2019 Mar; 132(6):647-652. PubMed ID: 30855344
[TBL] [Abstract][Full Text] [Related]
13. Urinary miR-185-5p is a biomarker of renal tubulointerstitial fibrosis in IgA nephropathy.
Duan ZY; Bu R; Liang S; Chen XZ; Zhang C; Zhang QY; Li JJ; Chen XM; Cai GY
Front Immunol; 2024; 15():1326026. PubMed ID: 38426107
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Fibrinogen γ-chain as a potential urinary biomarker for renal interstitial fibrosis in IgA nephropathy.
Guan J; Wang M; Zhao M; Ni W; Zhang M
BMC Nephrol; 2023 Mar; 24(1):60. PubMed ID: 36941570
[TBL] [Abstract][Full Text] [Related]
15. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
Gong WY; Liu M; Luo D; Liu FN; Yin LH; Li YQ; Zhang J; Peng H
BMC Nephrol; 2019 Apr; 20(1):150. PubMed ID: 31039758
[TBL] [Abstract][Full Text] [Related]
16. Identification of inflammatory biomarkers in IgA nephropathy using the NanoString technology: a validation study in Caucasians.
Gaumond L; Lamarche C; Beauchemin S; Henley N; Elftouh N; Gerarduzzi C; Laurin LP
Inflamm Res; 2024 Mar; 73(3):447-457. PubMed ID: 38291238
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy.
Wang G; Kwan BC; Lai FM; Chow KM; Li PK; Szeto CC
Dis Markers; 2011; 30(4):171-9. PubMed ID: 21694443
[TBL] [Abstract][Full Text] [Related]
18. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive Urinary Monitoring of Progression in IgA Nephropathy.
Yang JYC; Sarwal RD; Fervenza FC; Sarwal MM; Lafayette RA
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510053
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy.
Yoon SY; Kim JS; Jung SW; Kim YG; Hwang HS; Moon JY; Lee SH; Seo JW; Seok J; Tae D; Jeong K
Sci Rep; 2023 Oct; 13(1):17201. PubMed ID: 37821628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
